Navigation Links
Stryker Launches New Technologies and Celebrates a Major Clinical Milestone at The American Academy of Orthopaedic Surgeons Conference
Date:3/9/2010

NEW ORLEANS, March 9 /PRNewswire/ -- Stryker Corporation's Orthopaedics division announced today that it will feature two of its latest hip systems at this year's annual American Academy of Orthopaedic Surgeons (AAOS) conference being held in New Orleans – the Rejuvenate Modular Primary Hip System and the ADM Mobile Bearing Acetabular System with X3. These advancements in hip technology aim to increase implant durability and stability, enhance patient mobility and give surgeons greater choice and efficiency in the operating room.

"Our team continues to partner with surgeons to develop and commercialize cutting-edge technologies and products, such as Rejuvenate and ADM, that aim to enhance patient outcomes and streamline surgeons' operating room efficiency," said Mike Mogul, group president of Stryker Orthopaedics.

A testament to its commitment to technological longevity and clinical results through value-based product offerings, Stryker's Exeter hip stem is celebrating both its 40th anniversary and one millionth manufacturing during 2010. Despite the availability of newer, more expensive hip systems, the UK National Joint Registry confirms that the Exeter hip system is one of the best performing hip systems in the world(1).


'/>"/>
SOURCE Stryker Orthopaedics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Stryker to Host Conference Call on April 20, 2010
2. Stryker to Present at Investor Conference
3. Stryker Interventional Spine Launches VertaPlex(R) HV
4. Stryker to Host Analyst Meeting
5. Stryker Corporation Announces Pricing of Senior Notes
6. Stryker Updates Expected 2009 Results and Provides 2010 Outlook
7. Stryker Completes Acquisition of Ascent Healthcare Solutions
8. Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend
9. RoundTable Healthcare Partners Announces Sale of Ascent Healthcare Solutions to Stryker Corporation
10. Stryker Announces Agreements To Acquire Assets
11. Stryker Modifies Its Dividend Policy and Declares Transition Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... YORK, Pa. , July 29, 2015  Unilife ... and ASX: UNS), a developer, manufacturer and supplier of ... a multifaceted financing strategy that provides the Company with ... Unilife has signed an equity purchase ... Capital Fund, LLC ("LPC"), a Chicago ...
(Date:7/29/2015)... July 29, 2015  Nektar Therapeutics (Nasdaq: NKTR ) ... June 30, 2015 on Wednesday, August 5, 2015, after the ... and chief executive officer, will host a conference call to ... p.m. Pacific Time (PT). The press release ... be accessed through a link that is posted on the ...
(Date:7/29/2015)... and BERKELEY, Calif. , ... Plexxikon Inc., a member of the Daiichi Sankyo Group, ... Medicine (NEJM) published clinical trial results demonstrating that ... induced prolonged tumor regressions in most patients with tenosynovial ... of the joint or tendon sheath. Following ...
Breaking Medicine Technology:Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 3Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 2Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 3Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 4Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 5
... SAN FRANCISCO, Oct. 17 Proteolix, Inc. today announced ... will be presented at the 2009 ACR/ARHP Annual Scientific ... Carfilzomib is the first in a new class ... patients in multiple oncology clinical trials, including a Phase ...
... Oct. 16 Pfizer Inc., through a wholly owned subsidiary, ... federal district court in Boston as part of a plea ... the illegal marketing of the painkiller Bextra for unsafe and ... pharmaceutical company had for patients, lives by putting profits above ...
Cached Medicine Technology:Proteolix to Present Preclinical Data on Carfilzomib and PR-957 at the 2009 ACR/ARHP Annual Meeting 2Proteolix to Present Preclinical Data on Carfilzomib and PR-957 at the 2009 ACR/ARHP Annual Meeting 3Whistleblower's Attorney Says Pfizer's Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies 2
(Date:7/30/2015)... ... July 30, 2015 , ... ... New Tool That Increases Training Capability , World renown body weight ... Zejax ( http://www.Zejax.com ), that dramatically increases a person’s training capability. , The ...
(Date:7/30/2015)... ... July 30, 2015 , ... Using the latest online ... teach people more effective ways to prevent and manage major depression. , “Suicide is ... enough, so people fall through the cracks and die needlessly everyday,” says Walker. “I’m ...
(Date:7/30/2015)... ... ... On July 23rd Clay Today Online reported the state of Florida ... system, which has amassed largely enough throughout the years. Florida is the third state ... recent reduction of non violent drug offender’s prison sentences, Florida is beginning to take ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Ocean Hills ... available, including the very rare “no recommendations.” No recommendations means CARF found no areas ... is a notation that less than 3% of all facilities receive. In addition, Ocean ...
(Date:7/30/2015)... Newark, NJ (PRWEB) , ... July 30, 2015 ... ... New Jersey's State-designated entity on behalf of the New Jersey Department of Health, ... for Health Information Technology, an agency of the U.S. Department of Health and ...
Breaking Medicine News(10 mins):Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2
... Reporter , WEDNESDAY, Nov. 17 (HealthDay News) -- An ... to have passed an initial hurdle by proving safe ... designed to look at safety, researchers scheduled to present ... meeting in Chicago also report that anacetrapib raised HDL ...
... News) -- The U.S. Food and Drug Administration on Wednesday ... illegal. In warning letters to the companies, the agency ... "unsafe food additive," and the companies risked further action, including ... for the claim that the addition of caffeine to these ...
... named Walter and Eliza Hall Institute researcher Dr Benjamin Kile ... Minister,s Prize for Life Scientist of the Year is awarded ... the potential to advance, human welfare. Dr Kile, ... be presented with the award tonight by the Hon. Kim ...
... Institute of Public Health (NIPH) shows that children with severe ... 18 months of age compared to healthy children. Children with ... not show an increased risk of anxiety. - ... heart defects are prone to emotional problems at a very ...
... not have a chance to fight health problems if ... Non-adherence to medications costs thousands of lives and billions ... according to the New England Healthcare Institute. Now, researchers ... strategy that is three times more effective than previously ...
... that patients suffering back pain get quicker diagnosis and ... Traditionally, patients face long and anxiety-ridden wait times - ... by a spine surgeon. Results from the year long ... a Nurse Practitioner were significantly shorter, ranging from 10 ...
Cached Medicine News:Health News:Experimental Drug Raises Good Cholesterol Levels in Early Trial 2Health News:Experimental Drug Raises Good Cholesterol Levels in Early Trial 3Health News:FDA Cracks Down on Caffeinated Alcohol Drinks 2Health News:FDA Cracks Down on Caffeinated Alcohol Drinks 3Health News:Dr. Benjamin Kile named 2010 Australian Life Scientist of the Year 2Health News:Doubled risk of anxiety for 18 month-old children with congenital heart defects 2Health News:Researchers fight America's 'other drug problem' 2Health News:Toronto Western Hospital study demonstrates improved wait times for patients suffering back pain 2
... HCFA Evaluation and Management guidelines in selecting billing ... information, it calculates the HCFA scores for each ... the effect of changing different parts of the ... you entered to create an audit trail of ...
... Coder is simply more than ... a handheld solution for accurate ... both individual physicians and small ... now comes in three versions ...
... is a computerized medical reference ... encompasses a wide array of ... sets and decision tree analysis ... medical educators, nurses and health ...
... mobileMICROMEDEX™ gives physicians, ... professionals reliable clinical information ... confirm treatment decisions. Clinicians ... in mobileMICROMEDEX because all ...
Medicine Products: